NO20012944L - Fosfolipidkomplekser av proantocyanidin A2 som anti- aterosklerotiske midler - Google Patents

Fosfolipidkomplekser av proantocyanidin A2 som anti- aterosklerotiske midler

Info

Publication number
NO20012944L
NO20012944L NO20012944A NO20012944A NO20012944L NO 20012944 L NO20012944 L NO 20012944L NO 20012944 A NO20012944 A NO 20012944A NO 20012944 A NO20012944 A NO 20012944A NO 20012944 L NO20012944 L NO 20012944L
Authority
NO
Norway
Prior art keywords
proantocyanidin
atherosclerotic agents
phospholipid complexes
complexes
proanthocyanidin
Prior art date
Application number
NO20012944A
Other languages
English (en)
Other versions
NO20012944D0 (no
NO328733B1 (no
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of NO20012944D0 publication Critical patent/NO20012944D0/no
Publication of NO20012944L publication Critical patent/NO20012944L/no
Publication of NO328733B1 publication Critical patent/NO328733B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544Phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20012944A 1998-12-18 2001-06-14 Fosfolipidkomplekser av proantocyanidin A2, farmasoytisk sammensetning inneholdende kompleksene og anvendelse derav NO328733B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002732A IT1304183B1 (it) 1998-12-18 1998-12-18 Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
PCT/EP1999/009854 WO2000037062A2 (en) 1998-12-18 1999-12-13 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents

Publications (3)

Publication Number Publication Date
NO20012944D0 NO20012944D0 (no) 2001-06-14
NO20012944L true NO20012944L (no) 2001-06-14
NO328733B1 NO328733B1 (no) 2010-05-03

Family

ID=11381268

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012944A NO328733B1 (no) 1998-12-18 2001-06-14 Fosfolipidkomplekser av proantocyanidin A2, farmasoytisk sammensetning inneholdende kompleksene og anvendelse derav

Country Status (22)

Country Link
US (1) US6429202B1 (no)
EP (1) EP1140115B1 (no)
JP (1) JP4842436B2 (no)
KR (1) KR100694907B1 (no)
CN (1) CN1146429C (no)
AT (1) ATE238803T1 (no)
AU (1) AU763907B2 (no)
CA (1) CA2355776C (no)
CZ (1) CZ301495B6 (no)
DE (1) DE69907509T2 (no)
DK (1) DK1140115T3 (no)
ES (1) ES2197708T3 (no)
HK (1) HK1042430B (no)
HU (1) HU228928B1 (no)
IL (2) IL143751A0 (no)
IT (1) IT1304183B1 (no)
NO (1) NO328733B1 (no)
PL (1) PL197153B1 (no)
PT (1) PT1140115E (no)
RU (1) RU2248798C2 (no)
SK (1) SK284884B6 (no)
WO (1) WO2000037062A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8507018B2 (en) * 1998-03-12 2013-08-13 Mars, Incorporated Products containing polyphenol(s) and L-arginine and methods of use thereof
JP4634040B2 (ja) * 2002-02-12 2011-02-16 ウンザー ディ ピストレージ エルヴィラ エ チ. エッセ.ア.エッセ. リン脂質混合物、ホスホビオフラボン複合体及び該ホスホリオフラボン複合体を含む組成物
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
CA2554071C (en) * 2004-01-28 2013-05-07 Mars, Incorporated A-type procyanidins useful in the treatment of nitric oxide mediated disorders
EP1837030A1 (en) 2006-03-09 2007-09-26 INDENA S.p.A. Phospholipid complexes of curcumin having improved bioavailability
WO2009104556A1 (ja) * 2008-02-19 2009-08-27 株式会社岐阜セラツク製造所 組成物
IT1398624B1 (it) * 2009-02-02 2013-03-08 Dermogyn S R L Uso cosmetico della proantocianidina a2
RU2456674C1 (ru) * 2011-05-31 2012-07-20 Тагир Уралович Гафаров Способ моделирования атрофического рубца кожи
CN102688501A (zh) * 2012-06-20 2012-09-26 浙江萧山医院 原花青素b2磷脂复合物及其制备方法和用途
CN103120798A (zh) * 2013-01-10 2013-05-29 施冬云 一种具有抗氧化应激作用的磷脂复合物制备方法及其应用
CN103467778B (zh) * 2013-09-06 2015-09-30 天津大学 细菌纤维素/卵磷脂复合材料及制备和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698360B1 (en) 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IT1201151B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
US5648377A (en) * 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
IT1270999B (it) * 1994-07-26 1997-05-26 Indena Spa Formulazioni a base di cumarine e loro uso in campo farmaceutico e cosmetico
FI955691A (fi) 1994-11-28 1996-05-29 Suntory Ltd Lipoproteiini(a):ta alentava aine, kolesterolia alentava aine ja näitä aineita sisältävät lääkkeet
IT1296920B1 (it) * 1997-12-04 1999-08-03 Indena Spa Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-aterosclerotici
WO2001019009A1 (de) 1999-09-08 2001-03-15 Siemens Aktiengesellschaft Anordnung und verfahren für eine optische informationsübertragung

Also Published As

Publication number Publication date
SK284884B6 (sk) 2006-02-02
CZ301495B6 (cs) 2010-03-24
AU2283000A (en) 2000-07-12
JP4842436B2 (ja) 2011-12-21
ITMI982732A1 (it) 2000-06-18
HK1042430B (zh) 2004-10-08
US6429202B1 (en) 2002-08-06
DE69907509D1 (en) 2003-06-05
CN1146429C (zh) 2004-04-21
IL143751A (en) 2006-07-05
JP2002532543A (ja) 2002-10-02
CA2355776C (en) 2008-03-18
SK8602001A3 (en) 2001-12-03
HUP0104665A2 (hu) 2002-04-29
IL143751A0 (en) 2002-04-21
HK1042430A1 (en) 2002-08-16
HUP0104665A3 (en) 2003-01-28
HU228928B1 (en) 2013-06-28
NO20012944D0 (no) 2001-06-14
CA2355776A1 (en) 2000-06-29
NO328733B1 (no) 2010-05-03
IT1304183B1 (it) 2001-03-08
ATE238803T1 (de) 2003-05-15
DE69907509T2 (de) 2004-04-08
RU2248798C2 (ru) 2005-03-27
CZ20012134A3 (cs) 2001-12-12
EP1140115B1 (en) 2003-05-02
DK1140115T3 (da) 2003-08-25
ES2197708T3 (es) 2004-01-01
KR20010093826A (ko) 2001-10-29
KR100694907B1 (ko) 2007-03-14
WO2000037062A2 (en) 2000-06-29
PL197153B1 (pl) 2008-03-31
CN1330548A (zh) 2002-01-09
EP1140115A2 (en) 2001-10-10
PT1140115E (pt) 2003-08-29
AU763907B2 (en) 2003-08-07
WO2000037062A3 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
MA24694A1 (fr) Derives de thienopyrimidine et thienopyridine utiles comme agents anticancereux, et compositions les contenant.
ATE424835T1 (de) Methoden zur erhöhung der wirksamkeit von nicht- steroidalen antientzündlichen arzneien und dazu verwendbare zusammensetzungen enthaltend zwitterionische phospholipide
DE69940769D1 (de) Orale flüssige zusammensetzungen
NO20012944D0 (no) Fosfolipidkomplekser av proantocyanidin A2 som anti- aterosklerotiske midler
MXPA02012817A (es) Drogas antineoplasicas liposomales y uso de las mismas.
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
TR200100047T2 (tr) Tiyobenzimidazol türevleri
DE69925276D1 (de) Stoffe und zusammensetzungen für die verabreichung aktiver substanzen
IT1201149B (it) Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
TR199903331T2 (xx) Farnesil protein transferas engelleyicileri.
TR200103186T2 (tr) MEK enzimlerinin inhibitörleri olarak kinolin türevleri
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
ATE212351T1 (de) Androsten-derivate
NO20002827L (no) Anvendelse av fosfolipidkomplekser av Vitis vinifera som antiaterosklerotiske midler
NO20003674D0 (no) Faste, farmasøytiske preparater inneholdende miltefosin for oral administrering ved behandling av Leishmaniase
NO20040821L (no) 3-substituerte 6,7-dihydroksytetrahydroisokinolinderivater for andvendelse som antibakterielle midler.
ATE415965T1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
ATE218872T1 (de) Verfahren zur erhöhung der therapeutischen wirkung von nsaids und dazu verwendbare zwitterionische phospholipidhaltige zusammensetungen
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
IL139317A0 (en) Benzimdazole and benzoxazole derivatives and pharmaceutical compositions contining the same

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees